3b Blackbio Dx Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 21, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1202 as of 21 May 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 29 on March 2025 . This represents a CAGR of 72.48% over 5 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 58.9 on March 2025 . This represents a CAGR of 1.87% over 5 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 1387 crore on March 2025 . This represents a CAGR of 45.37% over 5 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 29228 crore on March 2025 . This represents a CAGR of 6.10% over 5 years The revenue of 3B Blackbio DX Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 55.93 crore. This represent the decline of -100% The revenue of Syngene International Ltd for the Mar '26 is ₹ 1058 crore as compare to the Dec '25 revenue of ₹ 932.5 crore. This represent the growth of 13.53% The ebitda of 3B Blackbio DX Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 27.3 crore. This represent the decline of -100% The ebitda of Syngene International Ltd for the Mar '26 is ₹ 319.6 crore as compare to the Dec '25 ebitda of ₹ 154 crore. This represent the growth of 107.53% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ 147.9 crore over 8 quarters. This represents a CAGR of 39.78% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 7.21 % on March 2025 . This represents a CAGR of -55.03% over 5 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 10.75 % on March 2025 . This represents a CAGR of 1.37% over 4 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of 3B Blackbio DX Ltd and Syngene International Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Syngene International Ltd?

Market cap of 3B Blackbio DX Ltd is 1,032 Cr while Market cap of Syngene International Ltd is 18,948 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Syngene International Ltd?

The stock performance of 3B Blackbio DX Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Syngene International Ltd?

As of May 21, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1202.7. On the other hand, Syngene International Ltd stock price is INR ₹470.25.

How do dividend payouts of 3B Blackbio DX Ltd and Syngene International Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.